Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01299480
What this trial is testing

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

Who this might be right for
Meningococcal Vaccine
Pfizer 1,714
Large-scale testing (Phase 3)Study completedNCT03165617
What this trial is testing

Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age

Who this might be right for
Influenza, Human
Seqirus 4,514
Testing effectiveness (Phase 2)Study completedNCT00300950
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Who this might be right for
Pancreas Cancer
GlobeImmune 176
Large-scale testing (Phase 3)Active Not RecruitingNCT06593210
What this trial is testing

RSV Vaccine in Transplant Recipients

Who this might be right for
Vaccine Response ImpairedRespiratory Syncytial Virus InfectionsImmune Suppression
University Health Network, Toronto 100
Early research (Phase 1)UnknownNCT06205524
What this trial is testing

Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

Who this might be right for
COVID-19COVID-19 Immunisation
National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College 100
Testing effectiveness (Phase 2)Study completedNCT04752644
What this trial is testing

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
RSV Infection
Bavarian Nordic 73
Testing effectiveness (Phase 2)Study completedNCT00764634
What this trial is testing

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Who this might be right for
Botulism Vaccine
DynPort Vaccine Company LLC, A GDIT Company 440
Post-approval studies (Phase 4)Study completedNCT04364399
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Who this might be right for
Mumps
Sinovac (Dalian) Vaccine Technology Co., Ltd. 920
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Early research (Phase 1)Active Not RecruitingNCT07183709
What this trial is testing

Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT02212990
What this trial is testing

The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine

Who this might be right for
Fever
Duke University 104
Early research (Phase 1)Study completedNCT01507779
What this trial is testing

Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine

Who this might be right for
Influenza
PATH 48
Large-scale testing (Phase 3)Study completedNCT01451086
What this trial is testing

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China

Who this might be right for
Healthy
Jiangsu Province Centers for Disease Control and Prevention 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07095868
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

Who this might be right for
Selected Types of Solid Tumor
Everest Medicines (Beijing) Co., Ltd. 94
Testing effectiveness (Phase 2)Study completedNCT05981846
What this trial is testing

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Who this might be right for
SARS CoV 2 InfectionInfluenza, Human
Hipra Scientific, S.L.U 279
Post-approval studies (Phase 4)Study completedNCT01222403
What this trial is testing

A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older

Who this might be right for
Influenza
Novartis Vaccines 767
Large-scale testing (Phase 3)Active Not RecruitingNCT06838000
What this trial is testing

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

Who this might be right for
Pneumococcal Infections
Sanofi Pasteur, a Sanofi Company 1,268
Early research (Phase 1)Study completedNCT00344539
What this trial is testing

AMA1-C1/Alhydrogel + CpG 7909 for Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 75
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Ended earlyNCT04919109
What this trial is testing

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Who this might be right for
Respiratory Syncytial Virus Infections
Codagenix, Inc 41
Next Page